Minnesota-based telehealth startup Zipnosis said it received an undisclosed capital investment from Fairview Health Services that will help the company expand its SaaS diagnosis and treatment option for minor health conditions.
As part of the agreement, Fairview, one of the largest not-for-profit systems in the state, will have a member on the Zipnosis board. The amount of the investment was not disclosed.
With the partnership, Zipnosis adds another health system to its client list that seeks to connect patients and local clinicians with the goal of reducing costs through telemedicine visits.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Patients can receive care for common medical conditions such as sinus infections, female bladder infections, pink eye, or cold, cough and flu through mobile phone, computer and tablet for a flat-rate $25-$35 service fee payable by a credit card or health savings card, according to Zipnosis, started in 2008.
Additionally, Zipnosis says the platform attracts new patients to health systems, in turn boosting revenue without adding more physicians or practitioners.
“Through funding and a more involved partnership, Fairview’s goal is to help provide Zipnosis the support it needs to further expand its virtual care capabilities and ultimately grow to meet the growing consumer demand for online health care,” said Dan Fromm, Fairview’s CFO.
Late last year, Zipnosis received a $1.5 million investment from Arthur Ventures. Its CEO and co-founder is Jonathan Pearce. Fairview, in partnership with the University of Minnesota, employs 22,000 and has 2,300 affiliated physicians.
